These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 28176270)

  • 61. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
    Cao W; Zhou J; Mann A; Wang Y; Zhu L
    Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Targeting CD133(+) laryngeal carcinoma cells with chemotherapeutic drugs and siRNA against ABCG2 mediated by thermo/pH-sensitive mesoporous silica nanoparticles.
    Qi X; Yu D; Jia B; Jin C; Liu X; Zhao X; Zhang G
    Tumour Biol; 2016 Feb; 37(2):2209-17. PubMed ID: 26353857
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In Situ Synthesis of Ultrathin ZIF-8 Film-Coated MSNs for Codelivering Bcl 2 siRNA and Doxorubicin to Enhance Chemotherapeutic Efficacy in Drug-Resistant Cancer Cells.
    Pan QS; Chen TT; Nie CP; Yi JT; Liu C; Hu YL; Chu X
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):33070-33077. PubMed ID: 30203954
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells.
    Babu A; Wang Q; Muralidharan R; Shanker M; Munshi A; Ramesh R
    Mol Pharm; 2014 Aug; 11(8):2720-33. PubMed ID: 24922589
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer.
    Scarano W; de Souza P; Stenzel MH
    Biomater Sci; 2015 Jan; 3(1):163-74. PubMed ID: 26214199
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapy.
    Qian J; Xu M; Suo A; Xu W; Liu T; Liu X; Yao Y; Wang H
    Acta Biomater; 2015 Mar; 15():102-16. PubMed ID: 25545322
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An approach to prepare polyethylenimine functionalized silica-based spheres with small size for siRNA delivery.
    Yu M; Niu Y; Yang Y; Hartono SB; Yang J; Huang X; Thorn P; Yu C
    ACS Appl Mater Interfaces; 2014 Sep; 6(18):15626-31. PubMed ID: 25184370
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hypoxia-induced tumor cell resistance is overcome by synergistic GAPDH-siRNA and chemotherapy co-delivered by long-circulating and cationic-interior liposomes.
    Guan J; Sun J; Sun F; Lou B; Zhang D; Mashayekhi V; Sadeghi N; Storm G; Mastrobattista E; He Z
    Nanoscale; 2017 Jul; 9(26):9190-9201. PubMed ID: 28650490
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
    Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
    Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
    [TBL] [Abstract][Full Text] [Related]  

  • 71. pH-sensitive micelles self-assembled from polymer brush (PAE-
    Huang X; Liao W; Zhang G; Kang S; Zhang CY
    Int J Nanomedicine; 2017; 12():2215-2226. PubMed ID: 28356738
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sequential therapy with redox-responsive glucolipid nanocarrier separately delivering siRNA and doxorubicin to overcome multidrug resistance.
    Meng T; Lu B; Shao S; Yuan M; Liu X; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Dec; 534(1-2):368-377. PubMed ID: 29051118
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacious cellular codelivery of doxorubicin and EGFP siRNA mediated by the composition of PLGA and PEI protected gold nanoparticles.
    Kumar K; Vulugundam G; Jaiswal PK; Shyamlal BRK; Chaudhary S
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4288-4293. PubMed ID: 28838699
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Polymer- and liposome-based nanoparticles in targeted drug delivery.
    Venkatraman SS; Ma LL; Natarajan JV; Chattopadhyay S
    Front Biosci (Schol Ed); 2010 Jun; 2(3):801-14. PubMed ID: 20515826
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Low-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor.
    Zhu WJ; Yang SD; Qu CX; Zhu QL; Chen WL; Li F; Yuan ZQ; Liu Y; You BG; Zhang XN
    Int J Nanomedicine; 2017; 12():3375-3393. PubMed ID: 28490877
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Targeted Drug Delivery System for Platinum-based Anticancer Drugs.
    Gao C; Zhang Y; Chen J; Wang T; Qian Y; Yang B; Dong P; Zhang Y
    Mini Rev Med Chem; 2016; 16(11):872-91. PubMed ID: 26586124
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier.
    Li JM; Zhang W; Su H; Wang YY; Tan CP; Ji LN; Mao ZW
    Int J Nanomedicine; 2015; 10():3147-62. PubMed ID: 25960653
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current status and future perspectives of gold nanoparticle vectors for siRNA delivery.
    Artiga Á; Serrano-Sevilla I; De Matteis L; Mitchell SG; de la Fuente JM
    J Mater Chem B; 2019 Feb; 7(6):876-896. PubMed ID: 32255093
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
    Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
    Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Encapsulation of verapamil and doxorubicin by MPEG-PLA to reverse drug resistance in ovarian cancer.
    Zheng W; Li M; Lin Y; Zhan X
    Biomed Pharmacother; 2018 Dec; 108():565-573. PubMed ID: 30243090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.